Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Potent and selective integrin inhibitors synthesized at Celltech

March 15, 2002

Kineret approved in E.U. for RA

March 14, 2002

Forest terminates agreement with Merckle for ML-3000

March 14, 2002

New lead cPLA2 inhibitor designed at AstraZeneca

March 13, 2002

University research leads to novel PLA2 inhibitors for the treatment of inflammatory diseases

March 12, 2002

Chugai identifies coumarin derivatives useful as TNF-alpha inhibitors

March 8, 2002

Cordase as a safe and effective alternative to surgery in Dupuytren's disease

March 7, 2002

Compounds inhibiting the production of IL-2 in T-lymphocytes patented by Boehringer Ingelheim

March 5, 2002

FDA approves Remicade for improvement of physical function in RA

March 5, 2002

BIRB-796BS investigated in humans for safety, pharmacokinetics and pharmacodynamics

March 5, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...